В. В. Кухарчук

1.5k total citations
91 papers, 737 citations indexed

About

В. В. Кухарчук is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, В. В. Кухарчук has authored 91 papers receiving a total of 737 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Surgery, 19 papers in Cardiology and Cardiovascular Medicine and 16 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in В. В. Кухарчук's work include Lipoproteins and Cardiovascular Health (40 papers), Antioxidant Activity and Oxidative Stress (12 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers). В. В. Кухарчук is often cited by papers focused on Lipoproteins and Cardiovascular Health (40 papers), Antioxidant Activity and Oxidative Stress (12 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers). В. В. Кухарчук collaborates with scholars based in Russia, United Kingdom and Germany. В. В. Кухарчук's co-authors include А. К. Тихазе, Г. Г. Коновалова, В. З. Ланкин, O. Afanasieva, S. Pokrovsky, Yu. N. Belenkov, М. В. Ежов, К. Б. Шумаев, О. И. Писаренко and Gert Kerkhoff and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and International Journal of Molecular Sciences.

In The Last Decade

В. В. Кухарчук

80 papers receiving 683 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
В. В. Кухарчук Russia 13 301 193 161 140 87 91 737
Yoshifumi Wada Japan 10 331 1.1× 388 2.0× 137 0.9× 114 0.8× 51 0.6× 14 877
Yuan-Teh Lee Taiwan 15 179 0.6× 296 1.5× 244 1.5× 72 0.5× 42 0.5× 25 886
Michele Nutini Italy 8 152 0.5× 218 1.1× 226 1.4× 49 0.3× 105 1.2× 9 1.0k
Takanori Nakajima Japan 13 240 0.8× 123 0.6× 347 2.2× 78 0.6× 54 0.6× 37 939
Michael Demosthenous Greece 11 384 1.3× 590 3.1× 151 0.9× 113 0.8× 54 0.6× 23 1.1k
Javier Navarro-Antolı́n Spain 12 402 1.3× 303 1.6× 295 1.8× 60 0.4× 54 0.6× 14 1.1k
J Mehta United States 13 153 0.5× 255 1.3× 110 0.7× 67 0.5× 67 0.8× 29 651
Johannes Pill Germany 17 173 0.6× 93 0.5× 412 2.6× 61 0.4× 52 0.6× 31 1.1k
Kirsten Müller Germany 6 528 1.8× 348 1.8× 277 1.7× 59 0.4× 111 1.3× 11 1.2k
R De Caterina Italy 17 215 0.7× 720 3.7× 185 1.1× 96 0.7× 30 0.3× 54 1.3k

Countries citing papers authored by В. В. Кухарчук

Since Specialization
Citations

This map shows the geographic impact of В. В. Кухарчук's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by В. В. Кухарчук with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites В. В. Кухарчук more than expected).

Fields of papers citing papers by В. В. Кухарчук

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by В. В. Кухарчук. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by В. В. Кухарчук. The network helps show where В. В. Кухарчук may publish in the future.

Co-authorship network of co-authors of В. В. Кухарчук

This figure shows the co-authorship network connecting the top 25 collaborators of В. В. Кухарчук. A scholar is included among the top collaborators of В. В. Кухарчук based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with В. В. Кухарчук. В. В. Кухарчук is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Кухарчук, В. В., А.В. Лисица, O. M. Ipatova, et al.. (2025). Water soluble peroral pharmaceutical form of phosphatidylcholine: experimental and clinical data in combined hyperlipidemia. Annals of the Russian academy of medical sciences. 80(1). 42–48.
2.
Shevchenko, Alexander I., М. С. Назаренко, М. В. Ежов, et al.. (2024). iPSC-Derived Endothelial Cells Reveal LDLR Dysfunction and Dysregulated Gene Expression Profiles in Familial Hypercholesterolemia. International Journal of Molecular Sciences. 25(2). 689–689. 3 indexed citations
3.
Назаренко, М. С., Alexander I. Shevchenko, Eugeny A. Elisaphenko, et al.. (2023). Calling and Phasing of Single-Nucleotide and Structural Variants of the LDLR Gene Using Oxford Nanopore MinION. International Journal of Molecular Sciences. 24(5). 4471–4471. 3 indexed citations
4.
Ежов, М. В., В. В. Кухарчук, И. В. Сергиенко, et al.. (2021). Existing problems and new possibilities in the treatment of dyslipidemia Joint Conclusion Based on the Results of the Expert Council. SHILAP Revista de lepidopterología. 17(1). 169–172. 2 indexed citations
5.
IuA, Karpov, et al.. (2021). Eurasian Guidelines for the diagnostics and management of stable coronary artery disease (2020-2021). SHILAP Revista de lepidopterología. 54–93. 4 indexed citations
6.
7.
Бубнова, М. Г. & В. В. Кухарчук. (2017). [Recommendations of the European Society of Cardiology and the European Atherosclerosis Society on Cardiovascular Disease Prevention and Management of Dyslipidemias. for the Diagnosis of Atherosclerosis and Dyslipidemia Treatment (2016): Basic S.G.]. PubMed. 57(3). 85–89. 2 indexed citations
8.
9.
Сергиенко, И. В., et al.. (2014). Lipoprotein-Associated Phospholipase A2 Serum Levels in Patients From Different Categories of Cardiovascular Risk. Kardiologiia. 3_2014(3). 57–63. 2 indexed citations
10.
Кухарчук, В. В., et al.. (2013). [Clinical role of lipoprotein-associated phospholipase A2].. PubMed. 53(3). 59–70. 3 indexed citations
11.
Рогоза, А. Н., et al.. (2010). Determination of the levels of brain natriuretic peptide and its N-terminal fragment for the evaluation of the efficiency of renal replacement therapy modalities in patients with decompensated chronic heart failure. SHILAP Revista de lepidopterología. 1 indexed citations
12.
Сергиенко, И. В., et al.. (2009). Various doses of statins and coronary angiogenesis in patients with coronary heart disease. SHILAP Revista de lepidopterología.
13.
Мешков, А. Н., et al.. (2007). Familial defect of apolipoprotein В-100: molecular disease basis and clinico-biochemical characteristics of the patients. SHILAP Revista de lepidopterología. 1 indexed citations
14.
Сергиенко, И. В., et al.. (2007). Myocardial revascularization effects on vascular endothelial growth factor and transforming growth factor β-1 in coronary heart disease patients. SHILAP Revista de lepidopterología. 1 indexed citations
15.
Ланкин, В. З., et al.. (2007). Effect of β-hydroxy-β-methylglutaryl coenzyme a reductase inhibitors and antioxidant vitamins on free radical lipid oxidation in rat liver. Bulletin of Experimental Biology and Medicine. 143(4). 414–417. 10 indexed citations
16.
Мешков, А. Н., et al.. (2006). Coronary heart disease development in heterozygotic form of familial hypercholesterolemia. SHILAP Revista de lepidopterología. 1 indexed citations
17.
Ланкин, В. З., А. К. Тихазе, В. В. Кухарчук, et al.. (2003). Antioxidants decreases the intensification of low density lipoprotein in vivo peroxidation during therapy with statins. Molecular and Cellular Biochemistry. 249(1-2). 129–140. 34 indexed citations
18.
Кухарчук, В. В., et al.. (2002). Sialyltransferase activity of human plasma and aortic intima is enhanced in atherosclerosis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1586(1). 123–128. 22 indexed citations
19.
Кухарчук, В. В., et al.. (2000). [Activity of chymotrypsin-like proteinases in patients with ischemic heart disease, arterial hypertension and nonspecific aortic arteritis].. PubMed. 72(11). 36–9. 1 indexed citations
20.
Pokrovsky, S., et al.. (1996). Lp(a)-APHERESIS : WHAT WE CAN SAY TODAY. 15. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshifumi Wada Breakdown of academic impact, for papers by Yuan-Teh Lee Breakdown of academic impact, for papers by Michele Nutini Breakdown of academic impact, for papers by Takanori Nakajima Breakdown of academic impact, for papers by Michael Demosthenous Breakdown of academic impact, for papers by Javier Navarro-Antolı́n Breakdown of academic impact, for papers by J Mehta Breakdown of academic impact, for papers by Johannes Pill Breakdown of academic impact, for papers by Kirsten Müller Breakdown of academic impact, for papers by R De Caterina
Rankless by CCL
2026